Elixinol Wellness logo

Elixinol Wellness(OTC) ELLXF

Market Cap$1.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year-41%
1 Month-53%
$0.00
-65.15%
-0.00Today
Elixinol Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-16
Elixinol Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-47.73%USD 0.002026-10-08
1 month-53.06%USD 0.002026-09-16
3 month-68.34%USD 0.012026-07-17
Year to date-73.56%USD 0.012025-12-31
1 year-41.03%USD 0.002025-10-15
3 year-94.87%USD 0.042023-10-17
5 year-99.56%USD 0.532021-10-15
Since inception-99.98%USD 10.222018-06-05

Elixinol Wellness Financials at a Glance

Market Cap

$1.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$30.93M

Net Income (TTM)

-A$5.54M

EPS (TTM)

-$0.01

P/E Ratio

-0.34

Dividend

$0.00

Beta (Volatility)

-0.47 (Low)

Price

$0.00

Volume

73

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Feb 19, 2027

ELLXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elixinol Wellness

Elixinol Wellness Limited is an Australian-based company established in 2017, specializing in the production and supply of hemp-derived products. The company offers a diverse range of wellness, beauty, and food items under its well-known brands, Elixinol and Hemp Foods Australia.

Products and Services
  • Comprehensive range of cannabidiol (CBD) products
  • Dietary supplements and various food items
  • Topicals and skincare solutions
Growth Outlook
  • Revenue of AUD 7.23 million in Q2 2026, showing market demand
  • Gross profit margin improved to 16.8% in Q2 2026
  • Expansion into international markets, including the Americas and Europe
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 30.5 million
  • Net income of AUD -1.08 million in Q2 2026, indicating ongoing investment
  • Current ratio of 0.78, reflecting liquidity management
Elixinol Wellness Limited operates in the healthcare sector, focusing on the growing demand for hemp-derived products. The company has established a solid presence in international markets, which is crucial for future growth. Recent financial data indicates a revenue of AUD 7.23 million for Q2 2026, reflecting a strong market demand for its products. The gross profit margin has also shown improvement, reaching 16.8%, which is a positive sign for operational efficiency. Despite reporting a net income loss of AUD 1.08 million in the latest quarter, the company continues to invest in its growth strategy, particularly in expanding its product offerings and market reach. The current ratio of 0.78 suggests that Elixinol is managing its liquidity effectively, which is essential for sustaining operations and funding future initiatives. Overall, Elixinol Wellness Limited presents an intriguing opportunity for investors interested in the hemp-derived product market.
AI Generated • Sep 28, 2026

Industry

Personal Products

CEO

Natalie Butler

Headquarters

Newtown, VIC 3220, AU

ELLXF Financials

Key Financial Metrics (TTM)

Gross Margin

11.03%

Operating Margin

-17.81%

Net Income Margin

-23.10%

Return on Equity

-50.35%

Return on Capital

-44.51%

Return on Assets

-22.93%

Earnings Yield

-2.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

454.11M

Volume

73

Avg. Volume

1.78K

Financials (TTM)

Gross Profit

A$7.54M

Operating Income

-A$8.19M

EBITDA

-A$6.66M

Operating Cash Flow

-A$5.25M

Capital Expenditure

-A$101.08K

Free Cash Flow

-A$5.35M

Cash & ST Invst.

A$994.60K

Total Debt

A$4.03M

Elixinol Wellness Performance Analysis

Elixinol Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31AUD 4,890,748-30.2%
20232023-12-31AUD 5,488,68312.2%
20242024-12-31AUD 9,864,96379.7%
20252025-12-31AUD 9,994,6151.3%
Elixinol Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3120.9%
Q22025-06-30-6.3%
Q42025-12-312.5%
Q22026-06-30-7.9%
Elixinol Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31AUD -0.14-42.9%
20232023-12-31AUD -0.07-54.6%
20242024-12-31AUD -0.01-88.9%
20252025-12-31AUD -0.0189.0%
Elixinol Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31300.0%
Q22025-06-30-348.2%
Q42025-12-3146.0%
Q22026-06-3065.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$7.23M

+6.8%

Gross Profit

A$1.21M

-49.7%

Gross Margin

16.80%

N/A

Market Cap

$1.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$13.74K

N/A

Employees

76

N/A

Net Income

-A$1.08M

+61.0%

EBITDA

-A$234.10K

+89.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$994.60K

-36.9%

Total Debt

A$4.03M

+240.6%

Accounts Receivable

A$1.60M

-20.2%

Inventory

A$2.25M

-44.7%

Long Term Debt

A$271.62K

+68.7%

Short Term Debt

A$3.76M

+268.2%

Return on Assets

-22.93%

N/A

Return on Invested Capital

-32.72%

N/A

Free Cash Flow

-A$736.45K

+66.4%

Operating Cash Flow

-A$715.35K

+66.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NPHCNutra Pharma Corp.
$0.00+0.00%
CSUICannabis Suisse Corp.
$0.01+0.00%
NGMCNext Generation Management Corp.
$1.03+0.00%
PAIOFPaion AG
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About ELLXF

What is the current price of Elixinol Wellness?

Elixinol Wellness is trading at $0.00 per share.

What is the 52-week range for Elixinol Wellness?

Over the past 52 weeks, Elixinol Wellness has traded between $0.00 and $0.02.

How much debt does Elixinol Wellness have?

As of the most recent reporting period, Elixinol Wellness reported total debt of A$2.49M.

How much cash does Elixinol Wellness have on hand?

Elixinol Wellness reported A$936.92K in cash and cash equivalents in its most recent financial results.

What is Elixinol Wellness’s dividend yield?

Elixinol Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.